Company / CapEx per Share
Bausch & Lomb Corp CapEx per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.99
FY2025
5-year range
$0.50 / $0.99
FY2021-FY2025
Trend
+19.1%
vs FY2024
Sector context
#61 of 142
Health Care
What the data says
At $0.99, Bausch & Lomb Corp's capex per share ranks #61 of 142 in the Health Care sector. CapEx per Share has increased for 3 consecutive years, from $0.50 in FY2022 to $0.99 in FY2025.
Based on SEC 10-K filings.
0.99 in FY2025 with a 5-year CAGR of +6.5%.
Improved from $0.52 to $0.99 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +25.6%
- 5-Year CAGR
- +6.5%
- 10-Year CAGR
- -
Sector benchmark
#61 of 142 in Health CareTop 43% of 142This company $0.99 Sector average $1.70
▼
-41.7% below sector average
Key checks
Key Insights
- Bausch & Lomb Corp's capex per share has grown for 3 consecutive years.
- In FY2025, capex per share increased 19.1% year-over-year.
- Ranks #61 out of 142 companies in the Health Care sector.
- Lowest capex per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.74 (distress zone, below 1.8 threshold)
- Negative profit margin: -6.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.99 | +19.1% |
| FY2024 | $0.83 | +60.8% |
| FY2023 | $0.52 | +3.4% |
| FY2022 | $0.50 | -9.3% |
| FY2021 | $0.55 | -23.7% |
| FY2020 | $0.72 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026